Cultivo de la línea celular HEp-2: doblaje poblacional y coloración con Giemsa Perspectivas para el estudio de la infección con Chlamydia trachomatis

dc.creatorJutinico Shubach, A P
dc.creatorMalagón Garzón, J
dc.creatorManrique Chacón, J N
dc.creatorGómez, M
dc.creatorSánchez Mora, R M
dc.date.accessioned2019-11-08T21:24:47Z
dc.date.accessioned2022-09-28T12:41:21Z
dc.date.available2019-11-08T21:24:47Z
dc.date.available2022-09-28T12:41:21Z
dc.date.created2019-11-08T21:24:47Z
dc.identifierhttps://repository.unad.edu.co/handle/10596/29963
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3636467
dc.publisherUniversidad Colegio Mayor de Cundinamarca
dc.relationhttp://hemeroteca.unad.edu.co/index.php/nova/article/view/1836/2051
dc.relation/*ref*/Draganov M, Fransazov S, Draganov D, Murdjeva M, Popov N. Two new serum free and protein free cell strains, derived from HEp-2 cell line: cultural conditions and proliferation activity. Journal of Culture Collections 2009;6(1):112-21.
dc.relation/*ref*/Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Periago MR. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2008;2(9):e300.
dc.relation/*ref*/Cervantes E. Infecciones causadas por Chlamydia trachomatis. Rev Fac Med UNAM 2009;52(1):18-22.
dc.relation/*ref*/Kubo T, Ishida K, Matsuo J, Nakamura S, Hayashi Y, Sakai H, et al. Chlamydia trachomatis serovar L2 infection model using human lymphoid Jurkat cells. Microb Pathog 2012 Jul;53(1):1-11.
dc.relation/*ref*/López E. Estudio de las características del ciclo de desarrollo de Chlamydia trachomatis relacionadas a la presencia del plásmido 7.5 Kb Instituto Politecnico Nacional; 2009.
dc.relation/*ref*/Kameswaran TR, Ramanibai R. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells. Biomed Pharmacother 2009 Feb;63(2):146-54.
dc.relation/*ref*/Wiedeman JA, Kaul R, Heuer LS, Thao NN, Pinkerton KE, Wenman WM. Tobacco smoke induces persistent infection of Chlamydophila pneumoniae in HEp-2 cells. Microb Pathog 2004 Sep;37(3):141-8.
dc.relation/*ref*/Hao H, Aixia Y, Dan L, Lei F, Nancai Y, Wen S. Baicalin suppresses expression of Chlamydia protease-like activity factor in Hep-2 cells infected by Chlamydia trachomatis. Fitoterapia 2009 Oct;80(7):448-52.
dc.relation/*ref*/Life Technologies Corporation. PrFont34Bin0BinSub0Frac- 0Def1Margin0Margin0Jc1Indent1440Lim0Lim11.http://www.invitrogen.com/site/us/en/home/support/Product-Technical-Resources/media_formulation.1.html. 20-2-2013.Ref Type: Online Source
dc.relation/*ref*/Sigma. http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Formulation/m4655for.Par.0001.File.tmp/m4655for.pdf. 20-2-2013. Ref Type: Online Source.
dc.relation/*ref*/Invitrogen.http://www.jbc.org/content/suppl/2009/02/26/M900773200.DC1/Schmidetal_Supplements.pdf. 20-2-2013. Ref Type: Online Source.
dc.relation/*ref*/Skinner MC, Kiselev AO, Isaacs CE, Mietzner TA, Montelaro RC, Lampe MF. Evaluation of WLBU2 peptide and 3-O-octylsn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis. Antimicrob Agents Chemother 2010 Feb;54(2):627-36.
dc.relation/*ref*/Lazarev VN, Polina NF, Shkarupeta MM, Kostrjukova ES, Vassi levski AA, Kozlov SA, et al. Spider venom peptides for gene therapy of Chlamydia infection. Antimicrob Agents Chemother 2011; Nov;55(11):5367-9.
dc.relation/*ref*/Life Technologies Corporation. HYPERLINK "http://www.invitrogen.com/site/us/en" http://www.invitrogen.com/site/us/en home/support/Product-Technical-Resources/media_formulation.1.html. 20-2-2013. Ref Type: Online Source.
dc.relation/*ref*/Invitrogen. HYPERLINK "http://www.jbc.org/content/suppl/2009/02/26" http://www.jbc.org/content/suppl/2009/02/26 M900773200. / Schmid etal _Supplements. pdf. 20-2-2013. Ref Type: Online Source.
dc.relation/*ref*/López E. Estudio de las características del ciclo de desarrollo de Chlamydia trachomatis relacionadas a la presencia del plásmido 7.5 Kb Instituto Politecnico Nacional; 2009.
dc.relation/*ref*/Sasiaín J, Instituto Nacional de Salud (Colombia). Reseña de " cien años del colorante Giemsa". Biomédica 2003 Mar;23:5-18.
dc.relation/*ref*/Lazarev VN, Polina NF, Shkarupeta MM, Kostrjukova ES, Vassilevski AA, Kozlov SA, et al. Spider venom peptides for gene therapy of Chlamydia infection. Antimicrob Agents Chemother 2011 Nov;55(11):5367-9.
dc.relation/*ref*/Yasin B, Pang M, Lehrer RI, Wagar EA. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp Mol Pathol 2003; Apr;74(2):190-5
dc.rightsCopyright (c) 2017 Nova
dc.rightshttp://creativecommons.org/licenses/by-nc-sa/4.0
dc.sourceNOVA Biomedical Sciences Journal; Vol. 11, Núm. 20 (2013); 23 - 33
dc.sourceNova; Vol. 11, Núm. 20 (2013); 23 - 33
dc.sourceNOVA Ciências Biomédicas Publicação; Vol. 11, Núm. 20 (2013); 23 - 33
dc.source2462-9448
dc.source1794-2470
dc.subjectChlamydia trachomatis; cultivo celular; doblaje poblacional; infección; línea celular HEp-2.
dc.titleCultivo de la línea celular HEp-2: doblaje poblacional y coloración con Giemsa Perspectivas para el estudio de la infección con Chlamydia trachomatis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typeinfo:eu-repo/article/published
dc.typeinfo:eu-repo/article/published
dc.typeinfo:eu-repo/article/published


Este ítem pertenece a la siguiente institución